Literature DB >> 3110661

Acquired cystic disease of the kidney in patients with end-stage chronic renal failure: a study of prevalence and aetiology.

B J Thomson, D A Jenkins, P L Allan, R A Elton, R J Winney.   

Abstract

Renal ultrasound scanning was performed in 100 patients with end-stage renal failure treated by both haemodialysis and continuous ambulatory peritoneal dialysis (CAPD). Each kidney was assessed for the presence of acquired cystic disease and solid lesions. The appearances were divided into five grades from grade 0 (no cysts detected) to grade 4 (greater than 15 cysts per kidney). Other intra-abdominal organs were also scanned for the presence of cysts. The findings were then correlated with possible aetiological factors, including the type of dialysis used. Sixty-three percent of all the patients had acquired cystic disease of the kidney (ACDK). No solid lesions were found and no cysts were detectable in other organs. The presence and grade of ACDK did not correlate with the age or sex of the patient, the nature of the underlying renal disease, or the duration of chronic renal failure. There was a significant correlation between the grade of ACDK and the duration of both haemodialysis (P less than 0.001) and CAPD (P less than 0.01). The presence of residual renal function did not influence the development of cysts. ACDK had no effect on haemoglobin or other laboratory parameters measured.

Entities:  

Mesh:

Year:  1986        PMID: 3110661

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

1.  Comparative study of cystic variations of the kidneys in haemodialysis and continuous ambulatory peritoneal dialysis patients.

Authors:  H Sasaki; Y Terasawa; Y Taguma; O Hotta; K Suzuki; K Nakamura
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 2.  Non-Hodgkin's lymphoma of the thyroid and adrenal glands.

Authors:  D H Lee; J H Park; J J Lee; I J Chung; D J Chung; M Y Chung; T H Lee
Journal:  Korean J Intern Med       Date:  2000-01       Impact factor: 2.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.